Marshall Summar

Summar is the Chief Executive Officer of Uncommon Cures. In 2022, he stepped down as Director of the Rare Disease Institute and as Chief of Genetics and Metabolism at Children's National Hospital in Washington D.C.. He was the Margaret O’Malley Professor of Genetic Medicine at Children’s National Health System in Washington, D.C. He’s also an Emeritus Professor in the Department of Pediatrics at the George Washington University School of Medicine & Health Sciences. Provided by Wikipedia